TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Cronos Australia Ltd. ( (AU:VIT) ).
Vitura Health Limited announced the presentation for its 2025 Annual General Meeting, highlighting its ongoing efforts to expand its digital health platform and product distribution capabilities. The company’s strategic initiatives, including its joint venture for psychedelic products and the integration of telehealth services, position it as a significant player in the evolving healthcare market, potentially impacting stakeholders by broadening access to innovative health solutions.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, operating through subsidiaries such as Burleigh Heads Cannabis, which manages the Canview platform—a comprehensive online ecosystem for prescribers, patients, pharmacies, and suppliers of therapeutic products in Australia. The company is involved in the sale and distribution of medicinal cannabis and other scheduled products, and it has ventured into the distribution of psychedelic products through a joint venture. Additionally, Vitura owns telehealth services like Doctors on Demand and CDA Clinics, and has a stake in Cortexa Pty Ltd, focusing on the supply of psychedelics for research and therapeutic use.
Average Trading Volume: 223,440
Technical Sentiment Signal: Sell
Current Market Cap: A$42.42M
See more insights into VIT stock on TipRanks’ Stock Analysis page.